• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anacor Pharmaceuticals Inc

+ Add to Watchlist

ANAC:US

33.4100 USD 0.2000 0.60%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Anacor Pharmaceuticals Inc (ANAC)

Open: 33.1300 Day's Range: 32.3000 - 33.5400 Volume: 1,744,548
Previous Close: 33.2100 52wk Range: 13.1900 - 37.4499 1-Yr Rtn: +97.69%

Stock Chart for ANAC

No chart data available.
  • ANAC:US 33.4100
  • 1D
  • 1M
  • 1Y
33.2100
Interactive ANAC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANAC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9511
Est. EPS (USD) (12/2014) -2.3200
Est. PEG Ratio -
Market Cap (M USD) 1,433.19
Shares Outstanding (M) 42.90
30 Day Average Volume 542,768
Price/Book (mrq) 20.9528
Price/Sale (ttm) 71.0446
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANAC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANAC

Anacor Pharmaceuticals Inc. is a biopharmaceutical company developing small-molecule therapeutics derived from our boron chemistry platform. The Company is focused on developing topical applications to treat fungal, bacterial and inflammatory diseases.

Paul L BernsPresident/CEOVincent P IppolitoExec VP/Chief Commercial Ofcr
Geoffrey M ParkerSenior VP/CFOKirk R MaplesSenior VP:Program Management
More Company Profile & Key Executives for ANAC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil